We provide you with 20 years of free, institutional-grade data for GTH stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GTH. Explore the full financial landscape of GTH stock.
| Reported Date | CIK | Ticker | Type |
|---|
Genetron Holdings Limited(NASDAQ:GTH) 
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services through laborato...
Website: https://www.genetronhealth.com/
Founded: 2015
Full Time Employees: 697
CEO: Si Zhen Wang
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
The information provided in this report about GTH stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.